Phase I Trial of 131I-HuCC49-deltaCH2 for Colon Cancer.
Phase of Trial: Phase I
Latest Information Update: 24 Jan 2013
At a glance
- Drugs Monoclonal antibody CC49 I-131 (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions
- 09 Nov 2005 Status changed from recruiting to completed.
- 29 Aug 2005 New trial record.